Covid 19
Feb 24, 2021

Amarex Featured in 15-year Anniversary Issue of the NSF International Journal

The just released Issue 48 of NSF International’s Health Science Journal features contributions by Amarex Clinical Research, LLC. This journal is available at https://www.nsf.org/periodicals/health-sciences-journal/issue-48.

Jan 18, 2021

Severe-to-Critical COVID-19 Patient Clinical Trial Reaches Full Enrollment

Our client’s Phase III clinical trial for patients with severe-to-critical COVID-19 symptoms reached full enrollment (390 patients) in mid-December. Data analysis results are expected this quarter. The trial was conducted in the U.S., Canada, and U.K.. 

Media / News Releases